Cargando…
What we know about surgical therapy in early-stage non-small-cell lung cancer: a guide for the medical oncologist
Lung cancer remains the leading cause of death in cancer patients. The gold standard for the treatment of early-stage non-small-cell lung cancer is lobectomy with mediastinal lymph-node dissection or systematic lymph-node sampling. The evidence behind this recommendation is based on the sole randomi...
Autores principales: | Ghanem, Sassine, El Bitar, Sandy, Hossri, Sami, Weerasinghe, Chanudi, Atallah, Jean Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505543/ https://www.ncbi.nlm.nih.gov/pubmed/28740431 http://dx.doi.org/10.2147/CMAR.S139253 |
Ejemplares similares
-
What do oncologists need to know about biosimilar products?
por: Leung, Linda K. S., et al.
Publicado: (2016) -
Renal Tubular Acidosis an Adverse Effect of PD-1 Inhibitor Immunotherapy
por: El Bitar, Sandy, et al.
Publicado: (2018) -
What the oncologist needs to know about COVID-19 infection in cancer patients
por: Rassy, Elie, et al.
Publicado: (2020) -
What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014) -
The gut microbiome: what the oncologist ought to know
por: Lee, K. A., et al.
Publicado: (2021)